Hemab Therapeutics 控股 COAG
$49.02 +$3.45 (+7.57%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $49.02 0.00%
开盘$46.18
昨收$45.57
当日区间$45.52 – $49.12
成交量428.0K
市值$2.29B
市盈率（TTM）–
股息率–
COAG 相关新闻
匹配 Hemab Therapeutics Holdings 或代码 COAG 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $60 正面
- Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $64 正面
- Hemab Therapeutics Holdings, Inc. (COAG) Gets a Buy From Wedbush
- Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $47 正面
- Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $55 正面
- H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Raises Target Price to $52 正面
- Jefferies Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $39
- Wedbush Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $42
- Hemab Therapeutics Holdings, Inc. (COAG) Receives a Buy From Wedbush
- H.C. Wainwright Maintains Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Maintains Target Price $40
- H.C. Wainwright Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $40
- Goldman Sachs Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $36
- Wedbush Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $42
- Evercore Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $50
- Jefferies Initiates Hemab Therapeutics Holdings(COAG.US) With Buy Rating, Announces Target Price $39
暂无评论——快来第一个聊聊 COAG。
登录后参与讨论。